Mankind Pharma ties up with Daewoong Pharmaceutical Co for c
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Mankind Pharma has collaborated with South Korean firm Daewoong Pharmaceutical Co for conducting phase-I clinical trial of a novel formulation of Niclosamide for the treatment of Covid-19 patients in India.

The trial is designed towards addressing the need for an investigation on this new formulation based on encouraging preclinical evidence for the treatment of Covid-19, Mankind Pharma said in a statement.

"We are excited to collaborate with Daewoong Pharmaceutical Co Ltd to bring novel formulation of Niclosamide (DWRX2003) for the treatment of Covid-19 patients in India."

"We believe that the product would provide for a safe and effective alternative to patients suffering from this disease," Mankind Pharma COO Arjun Juneja said.

Both the companies have received approval from the Drugs Controller General of India (DCGI) to conduct phase-1 clinical trials.

Daewoong Pharmaceutical CEO Sengho Jeon said, "Through the development of candidates for Covid-19 treatments such as Nicosamide, which Daewoong Pharmaceutical is currently developing, we expect to provide an innovative treatment option for patients suffering from Covid-19."

Source:
1. https://www.mankindpharma.com/
2. https://health.economictimes.indiatimes.com/news/pharma/mankind-pharma-ties-up-with-south-korean-co-for-clinical-trials-of-covid-19-drug/77505143
R●●●●●●a K●●●a and 7 others like this1 share
Like
Comment
Share
Dr. S●●●l G●●g
Dr. S●●●l G●●g General Medicine
Kar kal mkbkooks kknikhy ol
Sep 11, 2020Like
Dr. S●●●l G●●g
Dr. S●●●l G●●g General Medicine
I think mmmjujgtkkjjmjknmrujjmumimjmmmii noskanyyyhynhtbgybth kiubunkhnyb jjjmkkb ymmkijk
Sep 11, 2020Like